SCHEMBL5090684

SCHEMBL5090684

C[Si](C)(CCNC(=O)CCS)c1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
HPGD P15428 1/20 0.39
HDAC3 O15379 2/20 0.39
HDAC4 P56524 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC10 Q969S8 2/20 0.39
HDAC11 Q96DB2 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC9 Q9UKV0 2/20 0.39
HDAC5 Q9UQL6 2/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
HTT P42858 2/20 0.39
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
KMT2A Q03164 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5085616 0.87 HPGD (0.40) ALDH1A1HPGDHDAC3HDAC4HDAC1
SCHEMBL5097544 0.85 HPGD (0.46) HPGDHDAC3HDAC4HDAC1HDAC7
SCHEMBL5139867 0.85 HDAC3 (0.50) HPGDHDAC3HDAC4HDAC1HDAC7
SCHEMBL5134813 0.76 HDAC3 (0.42) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL4393657 0.73 KDM4E (0.39) CA1CA2CA9KMT2ALMNA
SCHEMBL4393659 0.73 KDM4E (0.39) CA1CA2CA9KMT2ALMNA
SCHEMBL5090836 0.72 LMNA (0.41) HPGDHDAC3HDAC4HDAC1HDAC7
SCHEMBL2003777 0.68 TAAR1 (0.41) TSHRKMT2ALMNA
SCHEMBL7320160 0.67 ALDH1A1 (0.64) ALDH1A1HPGDHDAC3HDAC4HDAC1
SCHEMBL928881 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1968609-A2 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF HIGHLY LIPOPHILIC SULFHYDRYL COMPOUNDS RND Pharmaceuticals, Inc. (US) 2008-09-17 EP disclosed
WO-2007073560-A2 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF HIGHLY LIPOPHILIC SULFHYDRYL COMPOUNDS RND PHARMACEUTICALS, INC. (US) 2007-06-28 WO disclosed